Immunology

Immune Drivers in Autoimmune Cytopenias Inform Patient Care

Understanding immune drivers in autoimmune cytopenias, discussed at EHA 2026, offers insights into targeted therapies and improved patient management.

CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management

Targeting CD19+ B-cells offers a corticosteroid-sparing strategy for IgG4-Related Disease, addressing relapse rates and long-term toxicity.

CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026

CAR T cell therapy demonstrates promising efficacy in refractory autoimmune diseases, offering a potential new therapeutic avenue for severe cases.

CAR T-Cell Therapy Shows Efficacy in Refractory Autoimmune Disease

CAR T-cell therapy, traditionally for cancer, demonstrates potential in severe autoimmune conditions, offering a new therapeutic avenue.

Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026

Managing hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) presents diagnostic and therapeutic challenges.

Immunological Insights Inform ILD & Transplant Outcomes

New immunological insights presented at ATS 2026 clarify mechanisms of interstitial lung disease progression and allograft rejection post-transplant.

Depression Screening Policies in Chronic Care

Addressing depression in chronic care settings is vital for improving patient outcomes. Culturally relevant screening programs may optimize the identification of at-risk individuals and facilitate access to appropriate mental health services.

Improving PID Diagnosis with Machine Learning Phenotype Profiling

Machine learning offers a promising avenue for quicker and more accurate diagnosis of primary immune dysregulation (PID), potentially reducing the diagnostic odyssey for affected patients. However, clinicians should view these tools as aids, not replacement...